Mon, 16 May 2022

Sputnik V highly effective against Omicron study
20 Jan 2022, 22:12 GMT+10

Russian-made vaccine works well in fighting new Covid variant, report indicates

The Russian Direct Investment Fund (RDIF), a state agency which funded the development of Sputnik V, quoted a report by a team from the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome and the Moscow-based Gamaleya National Center of Epidemiology and Microbiology, creators of the vaccine. Sputnik V offers "strong protection" against Omicron and produces twice as many Omicron-fighting antibodies as the alternative US/German formula made by Pfizer/BioNTech, the RDIF said.

The agency said researchers compared the effects of the Sputnik V and Pfizer vaccines against Omicron and the original SARS-CoV-2 virus that was first discovered in Wuhan, China in 2019. It added that the number of antibodies tailored to fight Omicron induced by Sputnik V was 2.6 times higher than those from the Pfizer vaccine after three months of immunization.

The agency said the new findings are in line with a December 2021 preprint published by Russian scientists online on medRxiv, which described how a booster shot of Sputnik Light prompted a "robust neutralizing antibody response" in people who had been fully vaccinated with Sputnik V. Sputnik Light is essentially a single-dose version of Sputnik V.

Sputnik V has been authorized for emergency use in around 70 countries, while Sputnik Light has been approved in more than 30.


More Italy News

Access More

Sign up for The Italy News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!